Clinical Trial Update: Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating insulin glargine dosing in hospitalized patients with type 2 diabetes and renal insufficiency; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency
• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Loyola University | Conditions: Type 2 Diabetes, Renal Insufficiency | Phase 4 | Status: COMPLETED | Results posted: 2017-03-10